Twist Bioscience Corporation Common Stock —— 图表、价格与新闻 (NASDAQ:TWST)

展开完整图表

Financials

概览声明统计

每季度年度

Market Capitalization 3.52 B
Employee 979
Founded 2013
CEO Emily LeProust
Website www.twistbioscience.com
Headquarter Delaware, United States
FIGI BBG006KDCHJ4
Industry Technology

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

3.52 B 市值

市盈率

-21.65

市销率

4.47

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.